Price target upside
Adaptive Biotechnologies Corporation - Common Stock Price Target Upside or Downside
ADPT price target upside based on the current price and analyst average.
Direct answer
Adaptive Biotechnologies Corporation - Common Stock's analyst target implies +0.6%.
The average target is $25.07 compared with a recorded current price of $24.93.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 8, 2026.
Get free Adaptive Biotechnologies Corporation - Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $24.93
- Average price target
- $25.07
- High price target
- $28.00
- Low price target
- $21.00
- Target upside
- +0.6%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- August 8, 2026
- Valid through
- August 15, 2026